INTRODUCTIONDespite being an exceptionally common disease, the exact pathogenesis of acne has not yet been fully elucidated. The hair follicle and sebaceous gland make up the pilosebaceous unit and acne…
Read More
We, as dermatologists, are exceedingly lucky. We can watch our patients improve before our eyes. In clinical practice, we don't often track a quantitative metric to gauge success but rather…
Read More
In this supplement Topical Acne Therapies and Their Pathogenic Targets We, as dermatologists, are exceedingly lucky. We can watch our patients improve before our eyes. In clinical practice, we don't…
Read More
INTRODUCTIONIn the treatment of acne, therapies that address multiple pathophysiological pathways are recommended for most patients.1 Combination therapies are generally more efficacious; in a meta-analysis of 221 clinical trials of…
Read More
INTRODUCTIONHypochlorous acid (HOCl) is one of the latest skincare ingredients to gain widespread popularity on social media. Despite newfound interest by some, the use of HOCl is certainly not new;…
Read More
INTRODUCTIONThere is a poor understanding at this time as to best- practice in recording outcomes in vitiligo. This is because there is an extremely heterogeneous set of publications with limited…
Read More
To the Editor: We read with interest the case of a post-hyaluronic acid (HA) filler reaction treated with abrocitinib, a JAK inhibitor (JAKi), by Lopez and colleagues.1 The article brings…
Read More
INTRODUCTIONWe read with great interest the Cartwright et al paper "The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers".1 Within dermatology, there is now…
Read More
INTRODUCTIONThe role of the vehicle in topical prescription treatments is to deliver therapeutic concentrations of an active drug to a designated skin target site to support patient adherence and satisfaction,…
Read More
INTRODUCTIONAtopic dermatitis (AD) is one of the most prevalent inflammatory skin conditions, characterized by recurrent eczema with varying degrees of erythema, pruritus, xerosis, and pain. Pruritus is a cardinal indicator…
Read More
INTRODUCTIONSince the release of the first FDA-approved targeted biologic agent in 2017, several years have elapsed since a new systemic therapy has been approved for atopic dermatitis (AD). Now, however,…
Read More
INTRODUCTIONGranuloma annulare (GA) is a benign, non-infectious cutaneous granulomatous disease with an estimated prevalence of up to 0.06% in the United States.1 It typically presents as skin colored to erythematous…
Read More
